Duloxetine

This classification denotes an antidepressant agent with the molecular formula C18H19NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O5TNM5N07U, chemically known as 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one but generally known as duloxetine, which bears US NIH Compound Identifier 3151. European Medicines Agency schedules Duloxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06424MIG. The term DULOXETINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules duloxetine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule duloxetine under HS 29349990 and SITC 51579. As of Q4 2014, DULOXETINE remains the US FDA Preferred Term for this commodity. Duloxetine bears US NLM identifiers UMLS ID C0245561 and NCI Concept Code C65495. SMILES: CLC1CC2[NH]C(=O)N(C3CCN(CC3)CCCN3C4C([NH]C3=O)CCCC4)C2CC1.